{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,8]],"date-time":"2026-10-08T14:24:03Z","timestamp":1791469443587,"version":"4.3.4"},"reference-count":42,"publisher":"Oxford University Press (OUP)","issue":"4","license":[{"start":{"date-parts":[[2015,9,1]],"date-time":"2015-09-01T00:00:00Z","timestamp":1441065600000},"content-version":"tdm","delay-in-days":1078,"URL":"http:\/\/doi.wiley.com\/10.1002\/tdm_license_1.1"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2012,10]]},"DOI":"10.1111\/j.1365-2133.2012.11160.x","type":"journal-article","created":{"date-parts":[[2012,7,21]],"date-time":"2012-07-21T03:02:56Z","timestamp":1342839776000},"page":"901-913","source":"Crossref","is-referenced-by-count":84,"title":["Congenital erythropoietic porphyria: a single-observer clinical study of 29 cases"],"prefix":"10.1093","volume":"167","author":[{"given":"R.P.","family":"Katugampola","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.N.","family":"Badminton","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A.Y.","family":"Finlay","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S.","family":"Whatley","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J.","family":"Woolf","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"N.","family":"Mason","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J.C.","family":"Deybach","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"H.","family":"Puy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C.","family":"Ged","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"H.","family":"de Verneuil","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S.","family":"Hanneken","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"E.","family":"Minder","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"X.","family":"Schneider-Yin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A.V.","family":"Anstey","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2012,9,18]]},"reference":[{"key":"10.1111\/j.1365-2133.2012.11160.x-BIB1|cit1","first-page":"2991","volume-title":"The Metabolic & Molecular Basis of Inherited Disease","author":"Anderson","year":"2001"},{"key":"10.1111\/j.1365-2133.2012.11160.x-BIB2|cit2","doi-asserted-by":"crossref","first-page":"779","DOI":"10.1046\/j.1365-2141.2002.03557.x","article-title":"Congenital erythropoietic porphyria: advances in pathogenesis and treatment","volume":"117","author":"Desnick","year":"2002","journal-title":"Br J Haematol"},{"key":"10.1111\/j.1365-2133.2012.11160.x-BIB3|cit3","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1016\/B978-0-08-092388-8.50009-1","volume-title":"The Porphyrin Handbook","author":"De Verneuil","year":"2003"},{"key":"10.1111\/j.1365-2133.2012.11160.x-BIB4|cit4","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1007\/BF01213085","article-title":"Regional assignment of the human uroporphyrinogen III synthase (UROS) gene to chromosome 10q25.2->q26.3","volume":"87","author":"Astrin","year":"1991","journal-title":"Hum Genet"},{"key":"10.1111\/j.1365-2133.2012.11160.x-BIB5|cit5","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1006\/geno.2000.6373","article-title":"Human uroporphyrinogen-III synthase: genomic organization, alternative promoters and erythroid-specific expression","volume":"70","author":"Aizencang","year":"2000","journal-title":"Genomics"},{"key":"10.1111\/j.1365-2133.2012.11160.x-BIB6|cit6","first-page":"53","article-title":"Congenital erythropoietic porphyria: mutation update and correlation between genotype and phenotype","volume":"55","author":"Ged","year":"2009","journal-title":"Cell Mol Biol (Noisy-le-Grand)"},{"key":"10.1111\/j.1365-2133.2012.11160.x-BIB7|cit7","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1007\/s100240010143","article-title":"Congenital erythropoietic porphyria: prenatal diagnosis and autopsy findings in two sibling fetuses","volume":"4","author":"Da\u00efkha-Dahmane","year":"2001","journal-title":"Pediatr Dev Pathol"},{"key":"10.1111\/j.1365-2133.2012.11160.x-BIB8|cit8","first-page":"121","article-title":"Biochemical diagnosis of a fatal case of G\u00fcnther\u2019s disease in a newborn with hydrops foetalis","volume":"31","author":"Verstraeten","year":"1993","journal-title":"Eur J Clin Chem Clin Biochem"},{"key":"10.1111\/j.1365-2133.2012.11160.x-BIB9|cit9","doi-asserted-by":"crossref","first-page":"594","DOI":"10.1016\/S0190-9622(97)70249-4","article-title":"Congenital erythropoietic porphyria","volume":"36","author":"Fritsch","year":"1997","journal-title":"J Am Acad Dermatol"},{"key":"10.1111\/j.1365-2133.2012.11160.x-BIB10|cit10","unstructured":"Katugampola RP Assessment of clinical and laboratory data to inform management decisions in congenital erythropoietic porphyria 2010"},{"key":"10.1111\/j.1365-2133.2012.11160.x-BIB11|cit11","doi-asserted-by":"crossref","first-page":"5","DOI":"10.3109\/17453054.2012.656584","article-title":"The role of photography in dermatology research","volume":"35","author":"Katugampola","year":"2012","journal-title":"J Vis Commun Med"},{"key":"10.1111\/j.1365-2133.2012.11160.x-BIB12|cit12","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1111\/j.1365-2230.1994.tb01167.x","article-title":"Dermatology Life Quality Index (DLQI): a simple practical measure for routine clinical use","volume":"19","author":"Finlay","year":"1994","journal-title":"Clin Exp Dermatol"},{"key":"10.1111\/j.1365-2133.2012.11160.x-BIB13|cit13","doi-asserted-by":"crossref","first-page":"942","DOI":"10.1111\/j.1365-2133.1995.tb16953.x","article-title":"The Children\u2019s Dermatology Life Quality Index (CDLQI): initial validation and practical use","volume":"132","author":"Lewis-Jones","year":"1995","journal-title":"Br J Dermatol"},{"key":"10.1111\/j.1365-2133.2012.11160.x-BIB14|cit14","volume-title":"The Measurement and Valuation of Health Status Using EQ-5D: A European Perspective","author":"Krabbe","year":"2003"},{"key":"10.1111\/j.1365-2133.2012.11160.x-BIB15|cit15","doi-asserted-by":"crossref","first-page":"528","DOI":"10.1111\/j.1365-2133.2006.07617.x","article-title":"The Family Dermatology Life Quality Index: measuring the secondary impact of skin disease","volume":"156","author":"Basra","year":"2007","journal-title":"Br J Dermatol"},{"key":"10.1111\/j.1365-2133.2012.11160.x-BIB16|cit16","doi-asserted-by":"crossref","first-page":"2618","DOI":"10.1182\/blood-2006-06-022848","article-title":"Congenital erythropoietic porphyria due to a mutation in GATA-1: the first trans-acting mutation causative for a human porphyria","volume":"109","author":"Phillips","year":"2007","journal-title":"Blood"},{"key":"10.1111\/j.1365-2133.2012.11160.x-BIB17|cit17","doi-asserted-by":"crossref","DOI":"10.1111\/j.1365-2133.2012.11154.x","article-title":"A management algorithm for congenital erythropoietic porphyria derived from a study of 29 cases","author":"Katugampola","year":"2012","journal-title":"Br J Dermatol"},{"key":"10.1111\/j.1365-2133.2012.11160.x-BIB18|cit18","doi-asserted-by":"crossref","first-page":"622","DOI":"10.1056\/NEJMc070009","article-title":"Pregnancy in a patient with congenital erythropoietic porphyria","volume":"357","author":"Hallai","year":"2007","journal-title":"N Engl J Med"},{"key":"10.1111\/j.1365-2133.2012.11160.x-BIB19|cit19","doi-asserted-by":"crossref","first-page":"659","DOI":"10.1111\/j.0022-202X.2005.23621.x","article-title":"Translating the science of quality of life into practice: what do Dermatology Life Quality Index scores mean?","volume":"125","author":"Hongbo","year":"2005","journal-title":"J Invest Dermatol"},{"issue":"Suppl. 1","key":"10.1111\/j.1365-2133.2012.11160.x-BIB20|cit20","first-page":"121","article-title":"Severity stratification of Children\u2019s Dermatology Life Quality Index (CDLQI) scores","volume":"163","author":"Waters","year":"2010","journal-title":"Br J Dermatol"},{"key":"10.1111\/j.1365-2133.2012.11160.x-BIB21|cit21","unstructured":"UK National Statistics http:\/\/www.statistics.gov.uk"},{"key":"10.1111\/j.1365-2133.2012.11160.x-BIB22|cit22","doi-asserted-by":"crossref","first-page":"498","DOI":"10.1111\/j.1525-1470.2003.20609.x","article-title":"Congenital erythropoietic porphyria complicated by squamous cell carcinoma","volume":"20","author":"Pandhi","year":"2003","journal-title":"Pediatr Dermatol"},{"key":"10.1111\/j.1365-2133.2012.11160.x-BIB23|cit23","doi-asserted-by":"crossref","first-page":"547","DOI":"10.1046\/j.1365-2133.1999.03057.x","article-title":"Congenital erythropoietic porphyria affecting two brothers","volume":"141","author":"Herrera","year":"1999","journal-title":"Br J Dermatol"},{"key":"10.1111\/j.1365-2133.2012.11160.x-BIB24|cit24","doi-asserted-by":"crossref","first-page":"1029","DOI":"10.1056\/NEJM198604173141607","article-title":"Complete suppression of the symptoms of congenital erythropoietic porphyria by long-term treatment with high-level transfusions","volume":"314","author":"Piomelli","year":"1986","journal-title":"N Engl J Med"},{"key":"10.1111\/j.1365-2133.2012.11160.x-BIB25|cit25","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1007\/BF02395763","article-title":"Radiological features in congenital erythropoietic porphyria (Gunther\u2019s disease): report of 3 cases","volume":"18","author":"Levesque","year":"1988","journal-title":"Pediatr Radiol"},{"key":"10.1111\/j.1365-2133.2012.11160.x-BIB26|cit26","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1111\/j.1365-2133.2008.08616.x","article-title":"Serum 25-hydroxyvitamin D in erythropoietic protoporphyria","volume":"159","author":"Holme","year":"2008","journal-title":"Br J Dermatol"},{"key":"10.1111\/j.1365-2133.2012.11160.x-BIB27|cit27","first-page":"865","article-title":"Congenital erythropoietic porphyria","volume":"45","author":"Singh","year":"2008","journal-title":"Indian Pediatr"},{"key":"10.1111\/j.1365-2133.2012.11160.x-BIB28|cit28","doi-asserted-by":"crossref","first-page":"526","DOI":"10.1007\/s004310051136","article-title":"Phototherapy sequela in a child with congenital erythropoietic porphyria","volume":"158","author":"Soylu","year":"1999","journal-title":"Eur J Pediatr"},{"key":"10.1111\/j.1365-2133.2012.11160.x-BIB29|cit29","doi-asserted-by":"crossref","first-page":"755","DOI":"10.1016\/0929-693X(96)81246-2","article-title":"Congenital erythropoietic porphyria. Apropos of a fatal case in the neonatal period due to acute hemolysis with hepatic failure","volume":"2","author":"De Verneuil","year":"1995","journal-title":"Arch Pediatr"},{"key":"10.1111\/j.1365-2133.2012.11160.x-BIB30|cit30","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1159\/000029857","article-title":"Congenital erythropoietic porphyria","volume":"11","author":"Fritsch","year":"1998","journal-title":"Skin Pharmacol Appl Skin Physiol"},{"key":"10.1111\/j.1365-2133.2012.11160.x-BIB31|cit31","first-page":"394","article-title":"Cyclophosphamide and congenital erythropoietic porphyria","volume":"2","author":"Bhutani","year":"1985","journal-title":"Photodermatology"},{"key":"10.1111\/j.1365-2133.2012.11160.x-BIB32|cit32","doi-asserted-by":"crossref","first-page":"1325","DOI":"10.1111\/j.1651-2227.1995.tb13561.x","article-title":"Congenital erythropoietic porphyria associated with nephrotic syndrome and renal siderosis","volume":"84","author":"Lange","year":"1995","journal-title":"Acta Paediatr"},{"key":"10.1111\/j.1365-2133.2012.11160.x-BIB33|cit33","doi-asserted-by":"crossref","first-page":"574","DOI":"10.1111\/j.1365-2133.2006.07472.x","article-title":"Erythropoietic protoporphyria in the U.K.: clinical features and effect on quality of life","volume":"155","author":"Holme","year":"2006","journal-title":"Br J Dermatol"},{"key":"10.1111\/j.1365-2133.2012.11160.x-BIB34|cit34","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1111\/j.1365-2133.2008.08581.x","article-title":"The quality of life of 790 patients with photodermatoses","volume":"159","author":"Jong","year":"2008","journal-title":"Br J Dermatol"},{"key":"10.1111\/j.1365-2133.2012.11160.x-BIB35|cit35","doi-asserted-by":"crossref","first-page":"502","DOI":"10.1111\/j.1365-2133.1997.tb02131.x","article-title":"Measure of quality of life in atopic dermatitis: correlation and validation of two different methods","volume":"136","author":"Herd","year":"1997","journal-title":"Br J Dermatol"},{"key":"10.1111\/j.1365-2133.2012.11160.x-BIB36|cit36","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1046\/j.1432-1327.1998.2570149.x","article-title":"Immunological, enzymatic and biochemical studies of uroporphyrinogen III-synthase deficiency in 20 patients with congenital erythropoietic porphyria","volume":"257","author":"Freesemann","year":"1998","journal-title":"Eur J Biochem"},{"key":"10.1111\/j.1365-2133.2012.11160.x-BIB37|cit37","doi-asserted-by":"crossref","first-page":"589","DOI":"10.1111\/j.0022-202X.2004.23401.x","article-title":"Congenital erythropoietic porphyria: report of a novel mutation with absence of clinical manifestations in a homozygous mutant sibling","volume":"123","author":"Ged","year":"2004","journal-title":"J Invest Dermatol"},{"key":"10.1111\/j.1365-2133.2012.11160.x-BIB38|cit38","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1016\/j.bcmd.2006.12.001","article-title":"Study of the genotype-phenotype relationship in four cases of congenital erythropoietic porphyria","volume":"38","author":"To-Figueras","year":"2007","journal-title":"Blood Cells Mol Dis"},{"key":"10.1111\/j.1365-2133.2012.11160.x-BIB39|cit39","doi-asserted-by":"crossref","first-page":"1443","DOI":"10.1182\/blood-2011-03-342873","article-title":"ALAS2 acts as a modifier gene in patients with congenital erythropoietic porphyria","volume":"118","author":"To-Figueras","year":"2011","journal-title":"Blood"},{"key":"10.1111\/j.1365-2133.2012.11160.x-BIB40|cit40","doi-asserted-by":"crossref","first-page":"753","DOI":"10.1172\/JCI10642","article-title":"Uroporphyrinogen III synthase erythroid promoter mutations in adjacent GATA1 and CP2 elements cause congenital erythropoietic porphyria","volume":"107","author":"Solis","year":"2001","journal-title":"J Clin Invest"},{"key":"10.1111\/j.1365-2133.2012.11160.x-BIB41|cit41","doi-asserted-by":"crossref","first-page":"980","DOI":"10.1046\/j.1365-2141.2002.03558.x","article-title":"Congenital erythropoietic porphyria: identification and expression of eight novel mutations in the uroporphyrinogen III synthase gene","volume":"117","author":"Shady","year":"2002","journal-title":"Br J Haematol"},{"key":"10.1111\/j.1365-2133.2012.11160.x-BIB42|cit42","doi-asserted-by":"crossref","first-page":"4053","DOI":"10.1182\/blood.V92.11.4053","article-title":"Congenital erythropoietic porphyria successfully treated by allogeneic bone marrow transplantation","volume":"92","author":"Tezcan","year":"1998","journal-title":"Blood"}],"container-title":["British Journal of Dermatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fj.1365-2133.2012.11160.x","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/onlinelibrary.wiley.com\/wol1\/doi\/10.1111\/j.1365-2133.2012.11160.x\/fullpdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,2,14]],"date-time":"2023-02-14T13:56:48Z","timestamp":1676383008000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/bjd\/article\/167\/4\/901\/6613984"}},"subtitle":["Single-observer clinical study of congenital erythropoietic porphyria"],"short-title":[],"issued":{"date-parts":[[2012,9,18]]},"references-count":42,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2012,10]]}},"URL":"https:\/\/doi.org\/10.1111\/j.1365-2133.2012.11160.x","relation":{},"ISSN":["0007-0963"],"issn-type":[{"value":"0007-0963","type":"print"}],"subject":[],"published":{"date-parts":[[2012,9,18]]}}}